Targeted knockdown of Notch1 inhibits invasion of human prostate cancer cells concomitant with inhibition of matrix metalloproteinase-9 and urokinase plasminogen activator.
Targeted knockdown of Notch1 inhibits invasion of human prostate cancer cells concomitant with inhibition of matrix metalloproteinase-9 and urokinase plasminogen activator.
复制标题
DOI:
10.1158/1078-0432.ccr-08-1631
复制
发表时间:
2009-01-15
期刊:
影响因子:
--
通讯作者:
Mukhtar H
中科院分区:
文献类型:
--
作者:
Bin Hafeez B;Adhami VM;Asim M;Siddiqui IA;Bhat KM;Zhong W;Saleem M;Din M;Setaluri V;Mukhtar H
Notch, a type 1 transmembrane protein, plays a key role in the development of many tissues and organ types. Aberrant Notch signaling found in a wide variety of human cancers contributes to tumor development. Since Notch1 was found to be over-expressed in prostate cancer (PCa) cells, and human PCa tissue we, therefore tested our hypothesis that over-expression of Notch1 in PCa promotes tumor invasion. Notch1 expression was evaluated in human PCa cells and in human PCa tissues. PCa cells were transiently transfected with Notch1 specific siRNAs in concentrations ranging from 30-120 nM and subsequently evaluated for effects on invasion and expression analysis for molecules involved in invasion. Small interfering RNA mediated knockdown of Notch1 in PCa PC3 and 22Rν1 cells dramatically decreased their invasion. Focused cDNA array revealed that Notch1 knockdown resulted in significant reduction in the expression of urokinase plasminogen activator (uPA) and matrix metalloproteinase (MMP)-9 gene transcripts. These data were further verified by RT-PCR, real- time RT-PCR and immunoblot analysis. Knockdown of Notch1 was also observed to significantly reduce the mRNA expression and protein levels of uPA and its receptor uPAR. A significant reduction in MMP9 expression in Notch1 knockdown cells suggested a role for Notch1 in augmenting MMP9 transcription. Our data demonstrate involvement of Notch1 in human PCa invasion and that silencing of Notch1 inhibits invasion of human PCa cells by inhibiting the expression of MMP9 and uPA. Thus, targeting of Notch1 could be an effective therapeutic approach against PCa.